
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
COMMD1 CRISPR/Cas9 KO Plasmid (h) | sc-404544 | 20 µg | $397.00 |
COMMD1 (copper metabolism MURR1 domain-containing protein 1) is a multifunctional adaptor protein that regulates ubiquitin-dependent signaling and membrane trafficking, with prominent roles in copper homeostasis and intracellular protein turnover. It modulates NF-κB transcriptional activity by influencing the stability and nuclear dynamics of key pathway components, thereby impacting inflammatory and stress-response programs. COMMD1 also interfaces with endosomal sorting machinery and ion transport processes, contributing to epithelial and hepatic physiology. Altered COMMD1 function has been linked to dysregulated metal handling, oxidative stress susceptibility, and aberrant inflammatory signaling relevant to studies of liver biology, metabolic stress, and cancer-associated signaling networks.
COMMD1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the COMMD1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the COMMD1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the COMMD1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish COMMD1 protein expression.
This CRISPR knockout system enables efficient generation of COMMD1-deficient cell models for investigation of COMMD1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.